Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase

被引:315
|
作者
Yoshida, K
Shimizugawa, T
Ono, M
Furukawa, H
机构
[1] Sankyo Co Ltd, Biomed Res Labs, Shinagawa Ku, Tokyo 1408710, Japan
[2] Sankyo Co Ltd, Pharmacol & Mol Biol Res Labs, Shinagawa Ku, Tokyo 1408710, Japan
关键词
KK/San; intravenous injection; plasma triglyceride;
D O I
10.1194/jlr.C200010-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Studies with KK/San, obese and diabetic model mice having a unique hypotriglyceridemia phenotype, revealed that angiopoietin-like protein 3 (ANGPTL3) regulates lipid metabolism in mice. To determine the lipid-modulating role of other ANGPTLs, we focused on ANGPTL4, which overall shows a significant similarity to ANGPTL3. Surprisingly, an intravenous injection of the ANGPTL4 protein in KK/San mice rapidly increased the circulating plasma lipid levels at a higher rate than ANGPTL3 protein. Furthermore, the ANGPTL4 protein inhibited the lipoprotein lipase activity in vitro.
引用
收藏
页码:1770 / 1772
页数:3
相关论文
共 50 条
  • [41] Development of an RNA Interference Therapeutic Targeting Angiopoietin-Like Protein 3 for Treatment of Hyperlipidemia
    Wong, So C.
    Zhu, Rui
    Hegge, Julia
    Schienebeck, Casi
    Christensen, Gary
    Trilling, Lucas
    Hamilton, Holly
    Briggs, Jeremy
    Hinkes, Meredith
    Bertin, Stephanie
    Andersen, Aaron
    Seefeld, Mark
    Li, Zhen
    CIRCULATION, 2018, 138
  • [42] Lipoprotein lipase and angiopoietin-like 4-Cardiomyocyte secretory proteins that regulate metabolism during diabetic heart disease
    Puthanveetil, Prasanth
    Wan, Andrea
    Rodrigues, Brian
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2015, 52 (03) : 138 - 149
  • [43] Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
    Babapoor-Farrokhran, Savalan
    Jee, Kathleen
    Puchner, Brooks
    Hassan, Syed Junaid
    Xin, Xiaoban
    Rodrigues, Murilo
    Kashiwabuchi, Fabiana
    Ma, Tao
    Hu, Ke
    Deshpande, Monika
    Daoud, Yassine
    Solomon, Sharon
    Wenick, Adam
    Lutty, Gerard A.
    Semenza, Gregg L.
    Montaner, Silvia
    Sodhi, Akrit
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (23) : E3030 - E3039
  • [44] Angiopoietin-like 4 Modifies the Interactions between Lipoprotein Lipase and Its Endothelial Cell Transporter GPIHBP1
    Chi, Xun
    Shetty, Shwetha K.
    Shows, Hannah W.
    Hjelmaas, Alexander J.
    Malcolm, Emily K.
    Davies, Brandon S. J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (19) : 11865 - 11877
  • [45] Angiopoietin-like protein 4 (Angptl4) expression is a poor prognosis factor of OSCC.
    Takuya, Tanaka
    Ogi, Hidenao
    Yoshida, Ryoji
    Hirosue, Akiyuki
    Hukuma, Daiki
    Kawahara, Kenata
    Mastuoka, Yuichiro
    Sakata, Jyunki
    Arita, Eisei
    Nakashima, Hikaru
    Takahisa, Imamura
    Nakayama, Hideki
    CANCER SCIENCE, 2018, 109 : 1010 - 1010
  • [47] Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4
    Ge, HF
    Yang, GQ
    Huang, L
    Motola, DL
    Pourbahrami, T
    Li, C
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (03) : 2038 - 2045
  • [48] Secretion of angiopoietin-like 4 protein from intestinal cells
    Nielsen, Soren Drud
    Jessen, Randi
    Dalsgaard, Trine Kastrup
    Young, Jette Feveile
    FUNCTIONAL FOODS IN HEALTH AND DISEASE, 2015, 5 (02): : 57 - 66
  • [49] Fasting-induced adipose factor/angiopoietin-like protein 4:: a potential target for dyslipidemia?
    Zandbergen, Fokko
    van Dijk, Susan
    Mueller, Michael
    Kersten, Sander
    FUTURE LIPIDOLOGY, 2006, 1 (02): : 227 - 236